AI biotech Xaira Therapeutics has revealed its generative AI antibody design platform, X-Design, along with the first details of its therapeutic pipeline. The Seattle-based company says X-Design is designed to create drug-ready antibodies and work alongside its X-Cell and X-Patient models to support AI-driven drug development.
AI Biotech Xaira Reveals Antibody Platform, First Taste of Pipeline
Share: